PERSPECTIVES Adenosine Receptors Find a New Partner and Move Out Myron L. Toews 1075 □ S Bring Your Own G Protein John D. Hildebrandt 1079 ORIGINAL ARTICLES The Ubiquitin-Specific Protease Usp4 Regulates the Cell Surface Level of the A 2a Receptor Tetyana Milojevi´ c, Veronika Reiterer, Eduard Stefan, Vladimir M. Korkhov, Mario M. Dorostkar, Eszter Ducza, Egon Ogris, Stefan Boehm, Michael Freissmuth, and Christian Nanoff 1083 Serine 202 Regulates the Nuclear Translocation of Constitutive Active/Androstane Receptor F. Hosseinpour, R. Moore, M. Negishi, and T. Sueyoshi 1095 Oral Benzo[a]pyrene in Cyp1 Knockout Mouse Lines: CYP1A1 Important in Detoxication, CYP1B1 Metabolism Required for Immune Damage Independent of Total-Body Burden and Clearance Rate Shigeyuki Uno, Timothy P. Dalton, Nadine Dragin, Christine P. Curran, Sandrine Derkenne, Marian L. Miller, Howard G. Shertzer, Frank J. Gonzalez, and Daniel W. Nebert 1103 Use of Penetrating Peptides Interacting with PP1/PP2A Proteins As a General Approach for a Drug Phosphatase Technology Julien Guergnon, Fr´ ed´ eric Dessauge, Victoria Dominguez, Jean Viallet, Serge Bonnefoy, Victor J. Yuste, Odile Mercereau-Puijalon, Xavier Cayla, Angelita Rebollo, Santos A. Susin, Pierre-Etienne Bost, and Alphonse Garcia 1115 Bafilomycin A1 Inhibits Chloroquine-Induced Death of Cerebellar Granule Neurons John J. Shacka, Barbara J. Klocke, Masahiro Shibata, Yasuo Uchiyama, Geeta Datta, Robert E. Schmidt, and Kevin A. Roth 1125 Emergence of Functional -Opioid Receptors Induced by Long-Term Treatment with Morphine Junyi Ma, Yong Zhang, Alex E. Kalyuzhny, and Zhizhong Z. Pan 1137 A Nonpeptide Antagonist Reveals a Highly Glycosylated State of the Rabbit Kinin B 1 Receptor Jean-Philippe Fortin, Edward K. Dziadulewicz, Lajos Gera, and Franc ¸ois Marceau 1146 MOLECULAR PHARMACOLOGY April 2006 Volume 69 Number 4 http://molpharm.aspetjournals.org ISSN 0026-895X The and symbols in the table of contents identify articles discussed in the Perspectives. Molecular Pharmacology (ISSN 0026-895X) is published monthly (two volumes per year beginning in January and July) by the Amer- ican Society for Pharmacology and Experimental Therapeutics, 9650 Rockville Pike, Bethesda, MD 20814-3995; e-mail: info@aspet.org; Web site: http://www.aspet.org. Periodicals postage paid at Bethesda, MD and at additional mailing offices. POSTMASTER: Send address changes to Molecular Pharmacology, 9650 Rockville Pike, Bethesda, MD 20814-3995. Subscription Rates: U.S.: $592.00 for institutions and $241.00 for non-ASPET members. Outside the U.S.: $673.00 for institutions and $322.00 for non-ASPET members. Single copy: $57.00. GST Tax Number for Canadian subscribers: BN:13489 2330 RT. Indexed or abstracted by Biochemistry & Biophysics Citation Index®, Biological Abstracts, BIOSIS Previews Database, Current Awareness in Biological Sciences, Current Contents®/Life Sciences, EMBASE/Excerpta Medica, Index Medicus, Medical Documentation Service®, Reference Update®, Research Alert®, Science Citation Index®, SciSearch®, and SIIC Data Bases. Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics. All rights reserved. Printed in the U.S.A. at ASPET Journals on December 3, 2021 molpharm.aspetjournals.org Downloaded from